{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:12:18Z","timestamp":1792098738672,"version":"4.4.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013161","name":"Swiss Life Stiftung f\u00fcr Chancenreichtum und Zukunft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008494","name":"Vontobel-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008494","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012654","name":"Olga Mayenfisch Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012654","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030184708\/1"],"award-info":[{"award-number":["310030184708\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["189003"],"award-info":[{"award-number":["189003"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["CRSII3_154405"],"award-info":[{"award-number":["CRSII3_154405"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.trsl.2020.07.008","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T03:07:37Z","timestamp":1595387257000},"page":"75-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"special_numbering":"C","title":["The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet"],"prefix":"10.1016","volume":"227","author":[{"given":"Emmanuel","family":"Somm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie A.","family":"Montandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Loizides-Mangold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ga\u00efa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Lazarevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"De Vito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Perroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Luce","family":"Bochaton-Piallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charna","family":"Dibner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Schrenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois R.","family":"Jornayvaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2020.07.008_bib0001","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2020.07.008_bib0002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0003","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrgastro.2010.191","article-title":"Animal models of nonalcoholic fatty liver disease","volume":"8","author":"Hebbard","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0005","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1139\/o90-079","article-title":"Reduction in VLDL, but not HDL, in plasma of rats deficient in choline","volume":"68","author":"Yao","year":"1990","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0006","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0016-5085(96)70028-8","article-title":"Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation","volume":"111","author":"Weltman","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2020.07.008_bib0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","article-title":"The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance","volume":"40","author":"Rinella","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0008","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2020.07.008_bib0009","doi-asserted-by":"crossref","first-page":"e25269","DOI":"10.1371\/journal.pone.0025269","article-title":"GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy","volume":"6","author":"Sharma","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2020.07.008_bib0010","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2010.09.032","article-title":"Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase","volume":"54","author":"Ben-Shlomo","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0011","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1478-3231.2011.02462.x","article-title":"Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis","volume":"31","author":"Svegliati-Baroni","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.trsl.2020.07.008_bib0012","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3892\/etm.2015.2741","article-title":"Liraglutide reduces fatty degeneration in hepatic cells via the AMPK\/SREBP1 pathway","volume":"10","author":"Wang","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.trsl.2020.07.008_bib0013","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/hep.23569","article-title":"Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway","volume":"51","author":"Gupta","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2020.07.008_bib0014","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jnutbio.2018.07.009","article-title":"Liraglutide modulates gut microbiota and reduces NAFLD in obese mice","volume":"62","author":"Moreira","year":"2018","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.trsl.2020.07.008_bib0015","doi-asserted-by":"crossref","first-page":"G225","DOI":"10.1152\/ajpgi.00274.2011","article-title":"Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL\/6J mice fed a Western diet","volume":"302","author":"Mells","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0016","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbrc.2018.09.134","article-title":"Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet","volume":"505","author":"Zhu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2020.07.008_bib0017","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/en.2013-2157","article-title":"Liraglutide enhances insulin sensitivity by activating AMP-activated protein kinase in male Wistar rats","volume":"155","author":"Yamazaki","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.trsl.2020.07.008_bib0018","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1248\/bpb.b14-00505","article-title":"The glucagon-like peptide-1 analogue liraglutide inhibits oxidative stress and inflammatory response in the liver of rats with diet-induced non-alcoholic fatty liver disease","volume":"38","author":"Gao","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.trsl.2020.07.008_bib0019","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/biof.1295","article-title":"Antiobesity efficacy of GLP-1 receptor agonist liraglutide is associated with peripheral tissue-specific modulation of lipid metabolic regulators","volume":"42","author":"Decara","year":"2016","journal-title":"Biofactors"},{"key":"10.1016\/j.trsl.2020.07.008_bib0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/hepr.12551","article-title":"Glucagon-like peptide-1 preserves non-alcoholic fatty liver disease through inhibition of the endoplasmic reticulum stress-associated pathway","volume":"46","author":"Ao","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.trsl.2020.07.008_bib0021","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2020.07.008_bib0022","first-page":"407","article-title":"Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes: the lira-NAFLD study","volume":"102","author":"Petit","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2020.07.008_bib0023","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2020.07.008_bib0024","doi-asserted-by":"crossref","first-page":"E8565","DOI":"10.1073\/pnas.1705821114","article-title":"Lipidomics reveals diurnal lipid oscillations in human skeletal muscle persisting in cellular myotubes cultured in vitro","volume":"114","author":"Loizides-Mangold","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2020.07.008_bib0025","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","article-title":"Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics","volume":"49","author":"Matyash","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2020.07.008_bib0026","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/bj1950301","article-title":"Alkaline O leads to N-transacylation. A new method for the quantitative deacylation of phospholipids","volume":"195","author":"Clarke","year":"1981","journal-title":"Biochem J"},{"key":"10.1016\/j.trsl.2020.07.008_bib0027","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.trsl.2020.07.008_bib0028","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/bioinformatics\/btt593","article-title":"PEAR: a fast and accurate Illumina Paired-End reAd mergeR","volume":"30","author":"Zhang","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.trsl.2020.07.008_bib0029","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nmeth.2604","article-title":"highly accurate OTU sequences from microbial amplicon reads","volume":"10","author":"Edgar","year":"2013","journal-title":"Nature Methods"},{"key":"10.1016\/j.trsl.2020.07.008_bib0030","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1128\/AEM.01541-09","article-title":"Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities","volume":"75","author":"Schloss","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0031","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1099\/ijsem.0.001755","article-title":"Introducing EzBioCloud: a taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies","volume":"67","author":"Yoon","year":"2017","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0032","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1093\/bioinformatics\/btq461","article-title":"Search and clustering orders of magnitude faster than BLAST","volume":"26","author":"Edgar","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.trsl.2020.07.008_bib0033","doi-asserted-by":"crossref","first-page":"R885","DOI":"10.1152\/ajpregu.00520.2015","article-title":"GLP-1 and weight loss: unraveling the diverse neural circuitry","volume":"310","author":"Kanoski","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0034","doi-asserted-by":"crossref","first-page":"G75","DOI":"10.1152\/ajpgi.00170.2018","article-title":"Lipid mediators of liver injury in nonalcoholic fatty liver disease","volume":"316","author":"Liangpunsakul","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2018.06.031","article-title":"Bioactive lipid species and metabolic pathways in progression and resolution of nonalcoholic steatohepatitis","volume":"155","author":"Musso","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2020.07.008_bib0036","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1742-4658.2010.07972.x","article-title":"Interruption of triacylglycerol synthesis in the endoplasmic reticulum is the initiating event for saturated fatty acid-induced lipotoxicity in liver cells","volume":"278","author":"Mantzaris","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.trsl.2020.07.008_bib0037","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.metabol.2012.12.001","article-title":"Fatty acid-mediated endoplasmic reticulum stress in vivo: differential response to the infusion of Soybean and Lard Oil in rats","volume":"62","author":"Nivala","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.trsl.2020.07.008_bib0038","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jnutbio.2007.10.001","article-title":"The role of fatty acids in the development and progression of nonalcoholic fatty liver disease","volume":"19","author":"Gentile","year":"2008","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.trsl.2020.07.008_bib0039","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.trsl.2017.10.004","article-title":"Macrophage polarization and meta-inflammation","volume":"191","author":"Li","year":"2018","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2020.07.008_bib0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0041","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1096\/fj.14-265983","article-title":"Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity","volume":"29","author":"Hwang","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2020.07.008_bib0042","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.chom.2013.09.012","article-title":"Microbial modulation of energy availability in the colon regulates intestinal transit","volume":"14","author":"Wichmann","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.trsl.2020.07.008_bib0043","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/genes8100250","article-title":"Effects of antidiabetic drugs on gut microbiota composition","volume":"8","author":"Montandon","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.trsl.2020.07.008_bib0044","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fendo.2019.00155","article-title":"The discovery and development of liraglutide and semaglutide","volume":"10","author":"Knudsen","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.trsl.2020.07.008_bib0045","doi-asserted-by":"crossref","first-page":"e50117","DOI":"10.1371\/journal.pone.0050117","article-title":"Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists","volume":"7","author":"Cuthbertson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2020.07.008_bib0046","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1507\/endocrj.EJ16-0449","article-title":"Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial","volume":"64","author":"Bouchi","year":"2017","journal-title":"Endocr J"},{"key":"10.1016\/j.trsl.2020.07.008_bib0047","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2015.08.038","article-title":"Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis","volume":"64","author":"Armstrong","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0048","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/1753-0407.12555","article-title":"Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease","volume":"9","author":"Feng","year":"2017","journal-title":"J Diabetes"},{"key":"10.1016\/j.trsl.2020.07.008_bib0049","first-page":"38","article-title":"Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease","author":"Tian","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1016\/j.trsl.2020.07.008_bib0050","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/hep.30320","article-title":"Liraglutide, sitagliptin, and insulin glargine added to metformin: the effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease","volume":"69","author":"Yan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2020.07.008_bib0051","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/dom.13007","article-title":"Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: a pilot randomized trial","volume":"19","author":"Khoo","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.trsl.2020.07.008_bib0052","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2337\/dc14-2548","article-title":"Effects of insulin glargine and liraglutide therapy on liver fat as measured by magnetic resonance in patients with type 2 diabetes: a randomized trial","volume":"38","author":"Tang","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2020.07.008_bib0053","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1007\/s00125-016-4100-7","article-title":"Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial","volume":"59","author":"Smits","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.trsl.2020.07.008_bib0054","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1194\/jlr.M600198-JLR200","article-title":"Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1","volume":"47","author":"Rizki","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2020.07.008_bib0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/labinvest.3700489","article-title":"Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARgamma agonist pioglitazone","volume":"87","author":"Leclercq","year":"2007","journal-title":"Lab Invest"},{"key":"10.1016\/j.trsl.2020.07.008_bib0056","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/JOE-15-0136","article-title":"Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21","volume":"226","author":"Camporez","year":"2015","journal-title":"J Endocrinol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0057","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cmet.2012.03.005","article-title":"Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance","volume":"15","author":"Jornayvaz","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2020.07.008_bib0058","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2174\/1389450116666150408103318","article-title":"Identification of lipid species linked to the progression of non-alcoholic fatty liver disease","volume":"16","author":"Kawano","year":"2015","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.trsl.2020.07.008_bib0059","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2217\/clp.13.67","article-title":"Lipid signals and insulin resistance","volume":"8","author":"Zhang","year":"2013","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0060","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","article-title":"CerS2 haploinsufficiency inhibits beta-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance","volume":"20","author":"Raichur","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2020.07.008_bib0061","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2020.07.008_bib0062","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.molmet.2018.12.008","article-title":"The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach","volume":"21","author":"Raichur","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/j.trsl.2020.07.008_bib0063","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.26606","article-title":"Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides","volume":"59","author":"Cinar","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2020.07.008_bib0064","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126910","article-title":"Ceramide as a mediator of non-alcoholic fatty liver disease and associated atherosclerosis","volume":"10","author":"Kasumov","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2020.07.008_bib0065","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1210\/jc.2017-00970","article-title":"GLP-1 receptor activation inhibits palmitate-induced apoptosis via ceramide in human cardiac progenitor cells","volume":"102","author":"Leonardini","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2020.07.008_bib0066","doi-asserted-by":"crossref","first-page":"29881","DOI":"10.1074\/jbc.M114.601864","article-title":"Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure","volume":"289","author":"Liu","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2020.07.008_bib0067","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1042\/BJ20111626","article-title":"Ceramide synthases at the centre of sphingolipid metabolism and biology","volume":"441","author":"Mullen","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.trsl.2020.07.008_bib0068","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1872-034X.2011.00934.x","article-title":"High fat diet induced hepatic steatosis and insulin resistance: role of dysregulated ceramide metabolism","volume":"42","author":"Longato","year":"2012","journal-title":"Hepatol Res"},{"key":"10.1016\/j.trsl.2020.07.008_bib0069","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-010-0409-6","article-title":"High fat diet induces ceramide and sphingomyelin formation in rat's liver nuclei","volume":"340","author":"Chocian","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.trsl.2020.07.008_bib0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2012.04.005","article-title":"Role of ceramides in nonalcoholic fatty liver disease","volume":"23","author":"Pagadala","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.trsl.2020.07.008_bib0071","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2337\/dc17-1318","article-title":"Specific hepatic sphingolipids relate to insulin resistance, oxidative stress, and inflammation in nonalcoholic steatohepatitis","volume":"41","author":"Apostolopoulou","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2020.07.008_bib0072","doi-asserted-by":"crossref","first-page":"40161","DOI":"10.1074\/jbc.M112.417014","article-title":"Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-alpha production","volume":"287","author":"Tosello-Trampont","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2020.07.008_bib0073","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage Polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0074","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbrc.2018.12.149","article-title":"Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway","volume":"510","author":"Li","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2020.07.008_bib0075","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/liv.12120","article-title":"GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK","volume":"33","author":"Zhang","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.trsl.2020.07.008_bib0076","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.biopha.2018.12.130","article-title":"Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - effects of a peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist and a glucagon-like peptide-1 analogue","volume":"111","author":"Daniels","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.trsl.2020.07.008_bib0077","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/496453","article-title":"The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone","volume":"2012","author":"Ohki","year":"2012","journal-title":"Scient World J"},{"key":"10.1016\/j.trsl.2020.07.008_bib0078","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/apt.12149","article-title":"Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program","volume":"37","author":"Armstrong","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.trsl.2020.07.008_bib0079","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/hepr.12351","article-title":"Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)","volume":"45","author":"Eguchi","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.trsl.2020.07.008_bib0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2020.07.008_bib0081","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1038\/onc.2017.38","article-title":"The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis","volume":"36","author":"Zhou","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2020.07.008_bib0082","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/cen.12369","article-title":"Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease","volume":"81","author":"Kahal","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.trsl.2020.07.008_bib0083","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0084","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41598-017-02866-y","article-title":"Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies","volume":"7","author":"de Mesquita","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2020.07.008_bib0085","doi-asserted-by":"crossref","first-page":"e136907","DOI":"10.1172\/jci.insight.136907","article-title":"Loss of Glp2r signaling activates hepatic stellate cells and exacerbates diet-induced steatohepatitis in mice","volume":"5","author":"Fuchs","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2020.07.008_bib0086","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0087","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.trsl.2015.08.002","article-title":"Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence","volume":"167","author":"Federico","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2020.07.008_bib0088","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.3748\/wjg.v24.i23.2468","article-title":"Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis","volume":"24","author":"Ye","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0089","doi-asserted-by":"crossref","first-page":"G911","DOI":"10.1152\/ajpgi.00225.2013","article-title":"Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model","volume":"305","author":"Okubo","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0090","doi-asserted-by":"crossref","first-page":"G151","DOI":"10.1152\/ajpgi.00198.2014","article-title":"Mosapride citrate improves nonalcoholic steatohepatitis with increased fecal lactic acid bacteria and plasma glucagon-like peptide-1 level in a rodent model","volume":"308","author":"Okubo","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0091","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.chom.2008.09.009","article-title":"Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine","volume":"4","author":"Ivanov","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.trsl.2020.07.008_bib0092","doi-asserted-by":"crossref","first-page":"12204","DOI":"10.1073\/pnas.0909122107","article-title":"Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota","volume":"107","author":"Round","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2020.07.008_bib0093","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.chom.2016.09.002","article-title":"Diverse intestinal bacteria contain putative zwitterionic capsular polysaccharides with anti-inflammatory properties","volume":"20","author":"Neff","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.trsl.2020.07.008_bib0094","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2010.11.049","article-title":"Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency","volume":"140","author":"Spencer","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2020.07.008_bib0095","doi-asserted-by":"crossref","first-page":"G288","DOI":"10.1152\/ajpgi.00453.2006","article-title":"Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats","volume":"293","author":"Simonsen","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.trsl.2020.07.008_bib0096","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.regpep.2012.08.016","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice","volume":"179","author":"Kissow","year":"2012","journal-title":"Regul Pept"},{"key":"10.1016\/j.trsl.2020.07.008_bib0097","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cmet.2015.02.005","article-title":"GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7","volume":"21","author":"Koehler","year":"2015","journal-title":"Cell Metab"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420301766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420301766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:13:17Z","timestamp":1778832797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524420301766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":97,"alternative-id":["S1931524420301766"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2020.07.008","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2020.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}